SEC Form 4 · accession 0001562180-16-003135
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amy Wolbeck
Officer — V.P. Regulatory Affairs & Qlty
Period of report
Sep 6, 2016
Accepted (ET)
Sep 8, 2016 · 6:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 6, 2016 | M | 12,376 | $0.72 | A | 18,076 | D | |
| Common StockF2 | Sep 6, 2016 | S | 7,624 | $15.8969 | D | 10,452 | D | |
| Common Stock | Sep 6, 2016 | M | 7,624 | $0.72 | A | 18,076 | D | |
| Common StockF2 | Sep 6, 2016 | S | 12,376 | $15.8969 | D | 5,700 | D | |
| Common Stock | Sep 7, 2016 | M | 8,664 | $0.72 | A | 14,364 | D | |
| Common StockF3 | Sep 7, 2016 | S | 8,664 | $15.6707 | D | 5,700 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $0.72 | Sep 6, 2016 | M | 7,624 | D | — | Jan 31, 2021 | Common Stock | 7,624 | 10,777 | D |
| Stock Option (right to buy)F5 | $0.72 | Sep 6, 2016 | M | 12,376 | D | — | Jan 31, 2021 | Common Stock | 12,376 | 2,344 | D |
| Stock Option (right to buy)F4 | $0.72 | Sep 7, 2016 | M | 8,664 | D | — | Jan 31, 2021 | Common Stock | 8,664 | 2,113 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 5, 2016.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.75 to $16.09, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.60 to $15.80, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4.
- F4The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option vest monthly over 48 months beginning March 1, 2011.
- F5The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option vest monthly over 48 months beginning February 28, 2013.